Richard Saynor has been CEO of Sandoz since July 15, 2019
Previously, Saynor was Senior Vice President, Classic and Established Products (CEP) at GSK from 13 September 2010. As SVP, CEP, he was responsible for driving top-line sales, leveraging the supply chain and maximising operating profit for post-patent products spanning six therapy areas (Respiratory, Allergy, Anti-infective, Neuroscience, Dermatology and Urology).
Richard brings with him over 20 years of experience in the Generics and Pharma industry. He has held senior leadership positions internationally and is well-versed in managing complex and diverse regions within the emerging markets of Latam and Asia, as well as more established markets in Europe and Canada.
A qualified Pharmacist, Richard graduated from Bradford University with a Bachelor of Pharmacy and is a member of the Royal Pharmaceutical Society.